<DOC>
	<DOCNO>NCT01622998</DOCNO>
	<brief_summary>The primary aim research study determine whether titrate , patient-directed transdermal patch NRT , base smoke history symptom nicotine withdrawal , improve long-term rate smoke cessation patient motivate quit smoking compare patient use standard transdermal NRT patch protocol . The following hypothesis test : CO-validated continuous abstinence rate 52 week post target quit date higher titrate , self-directed NRT group compare standard NRT treatment group .</brief_summary>
	<brief_title>Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment Smoking Cessation</brief_title>
	<detailed_description>Participants recruit UOHI Smoking Cessation Clinic via medium advertisement . Following baseline assessment , participant randomly assign one two group : 1 . 10-week standard treatment transdermal nicotine replacement therapy ( NRT ) ; 2 . 10-week titrated transdermal nicotine replacement therapy ( NRT ) treatment additional NRT product ( NRT+ ) Participants assign `` NRT '' standard treatment group follow 10-week regimen nicotine patch alone . Participants assign `` NRT+ '' titrate treatment group follow 10-week regimen tailor patch dosage . Participants also provide Nicorette inhaler . All participant receive five 15-minute counselling session smoke cessation counsellor . These session occur 1 , 3 , 5 , 8 10 week post target quit date . Counselling session focus practical counselling ( problem solve skill train ) social support . During treatment phase , participant complete questionnaire measure withdrawal symptom , self-efficacy , use cessation resource Beck Depression Inventory ( BDI-II ) week 1 , 3 , 5 , 8 10 . These questionnaire also complete 26 52 week post target quit date .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<criteria>1 . Current smoker ( ≥ 10 cigarette per day ) ; 2 . 18 year age old ; 3 . Willing set date quit smoking within 30 day follow baseline assessment ; 4 . Participant willing return UOHI followup examination ; 5 . Participant willing provide inform consent ; 6 . Motivated quit smoking . 1 . Participant unable read understand English French ; 2 . Participant pregnant , lactate plan become pregnant study period ; 3 . Participant attempt quit smoking previous month support medication &gt; 72 hour ; 4 . Participant currently use smoke cessation medication ( e.g. , NRT , Bupropion , Varenicline , Clonadine , Notriptyline ) ; 5 . Participant contraindication ( ) nicotine replacement therapy ( allergy adhesive , lifethreatening arrhythmia ( e.g. , tachycardia ) ; 6 . Participant immediate postmyocardial infarction period ( i.e . incident occur within last 10 day ) ; 7 . Severe worsen angina pectoris ; 8 . Subject recent cerebral vascular accident ( i.e . incident occur within last 10 day ) ; 9 . Participant currently suffer depression ( BDIII ≥20 ) ; 10 . Participant diagnose depression treat antidepressant past 12 month ; 11 . Past present history psychosis ( Schizophrenia , Schizophreniform Delusional Disorders ) , panic disorder , bipolar disorder ; 12 . Drug alcohol abuse dependence past year ; 13 . Member participant 's household already participate study `` Quit Smoking 'Real World ' '' study ; 14 . Participant currently participate already receive counsel followup smoking cessation . 13 . ) Participants opinion investigator unlikely commit yearlong study ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Titration</keyword>
	<keyword>Smoking Cessation</keyword>
</DOC>